FineMark National Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-211
| Closed | -$222K | – | 452 |
|
|
2024
Q3 | $222K | Hold |
211
| – | – | 0.01% | 394 |
|
|
2024
Q2 | $222K | Hold |
211
| – | – | 0.01% | 385 |
|
|
2024
Q1 | $203K | Buy |
+211
| New | +$203K | 0.01% | 406 |
|
|
2023
Q3 | – | Sell |
-487
| Closed | -$350K | – | 428 |
|
|
2023
Q2 | $350K | Buy |
+487
| New | +$350K | 0.01% | 321 |
|
|
2017
Q1 | – | Sell |
-220
| Closed | -$81K | – | 856 |
|
|
2016
Q4 | $81K | Hold |
220
| – | – | 0.01% | 523 |
|
|
2016
Q3 | $89K | Buy |
220
+153
| +228% | +$61.9K | 0.01% | 487 |
|
|
2016
Q2 | $23K | Sell |
67
-44
| -40% | -$15.1K | ﹤0.01% | 800 |
|
|
2016
Q1 | $40K | Sell |
111
-104
| -48% | -$37.5K | ﹤0.01% | 629 |
|
|
2015
Q4 | $117K | Buy |
215
+2
| +0.9% | +$1.09K | 0.01% | 419 |
|
|
2015
Q3 | $99K | Sell |
213
-84
| -28% | -$39K | 0.01% | 459 |
|
|
2015
Q2 | $151K | Sell |
297
-64
| -18% | -$32.5K | 0.02% | 388 |
|
|
2015
Q1 | $163K | Sell |
361
-14
| -4% | -$6.32K | 0.02% | 383 |
|
|
2014
Q4 | $154K | Sell |
375
-6
| -2% | -$2.46K | 0.02% | 401 |
|
|
2014
Q3 | $138K | Buy |
381
+195
| +105% | +$70.6K | 0.02% | 397 |
|
|
2014
Q2 | $52K | Buy |
186
+13
| +8% | +$3.63K | 0.01% | 624 |
|
|
2014
Q1 | $52K | Buy |
173
+26
| +18% | +$7.82K | 0.01% | 598 |
|
|
2013
Q4 | $40K | Buy |
147
+4
| +3% | +$1.09K | 0.01% | 630 |
|
|
2013
Q3 | $45K | Buy |
+143
| New | +$45K | 0.01% | 594 |
|